Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice

Nutrition Research

Volumn 29, Issue 2, 2009, Pages 139-143

  Nogusa, Shoko ^a   Gerbino, Jeffrey ^a   Ritz, Barry W ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

Flu; Lung virus; Mice; Mushroom; Natural killer cell; Survival

Indexed keywords

ACTIVE HEXOSE CORRELATED COMPOUND; HEXOSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DIET SUPPLEMENTATION; IMMUNE RESPONSE; INFLUENZA VIRUS; LUNG CLEARANCE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; VIRUS PNEUMONIA; WEIGHT REDUCTION;

ANIMALS; BASIDIOMYCOTA; BODY WEIGHT; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLUENZA A VIRUS; KILLER CELLS, NATURAL; LUNG; MALE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PHYTOTHERAPY; POLYSACCHARIDES; SPLEEN;

BASIDIOMYCOTA; INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 61749096620     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.01.005     Document Type: Article

References (17)

1. Aviles H., O'Donnell P., Orshal J., Fujii H., Sun B., and Sonnenfeld G. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am J Surg 195 (2008) 537-545
2. Aviles H., Belay T., Vance M., Sun B., and Sonnenfeld G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol 97 (2004) 1437-1444
3. Gao Y., Zhang D., Sun B., Fujii H., Kosuna K., and Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother 55 10 (2006) 1258-1266
4. Wang S., Wakame K., Igarashi Y., et al. Beneficial effects of active hexose correlated compound (AHCC) on immobilization stress in rat. Dokkyo J Med Sci 28 (2001) 559-565
5. Burikhanov R.B., Wakame K., Igarashi Y., Wang S., and Matsuzaki S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in rat. Endocr Regul 34 (2000) 181-188
6. Matsushita K., Kuramitsu Y., Ohiro Y., et al. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs 9 (1998) 343-350
7. Matsui Y., Uhara J., Satoi S., et al. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J Hepatol 37 (2002) 78-86
8. Uno K., Kosuna K., Sun B., et al. Active hexose correlated compound (AHCC) improves immunological parameters and performance status of patients with solid tumors. Biotherapy (Japan) 14 3 (2000) 303-309
9. Ghoneum M., Wimbley M., Salem F., McKlain A., Attallah N., and Gill G. Immunomodulatory and anticancer effects of active hexose correlated compound (AHCC). Int J Immunother 11 (1995) 23-28
10. Ritz B.W. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice. Nutr Rev 66 9 (2008) 526-531
11. Ritz B.W., Nogusa S., Ackerman E.A., and Gardner E.M. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr 136 (2006) 2868-2873
12. Ritz B.W., Aktan I., Nogusa S., and Gardner E.M. Energy restriction impairs natural killer cell function and increases the severity of influenza infection in young adult male C57BL/6 mice. J Nutr 138 (2008) 2269-2275
13. Po J.L., Gardner E.M., Anaraki F., Katsikis P.D., and Murasko D.M. Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection. Mech Ageing Dev 123 (2002) 1167-1181
14. Nogusa S., Ritz B.W., Kassim S.H., Jennings S.R., and Gardner E.M. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 129 (2008) 223-230
15. Plett P.A., Gardner E.M., and Murasko D.M. Age-related changes in interferon-α/β receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice. Mech Ageing Dev 118 (2000) 129-144
16. Guidance for Industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers (2005), U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville (Md). Available at: www.fda.gov/cder/guidance/index.htm
17. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S.J., and Gordon S. Dectin-1 mediates the biological effects of β-glucans. J Exp Med 197 9 (2003) 1119-1124